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Abstract
There is no conclusive evidence regarding a causal relationship between periodontitis and atherosclerosis. In this study, 
we examined the microbiome in the oral cavity and atheromatous plaques from atherosclerosis patients with or without 
periodontitis to investigate the role of oral bacteria in the formation of atheromatous plaques. We chose four patients with 
and without periodontitis, who had undergone carotid endarterectomy. Bacterial samples were extracted from the tongue 
surface, from periodontal pocket (during the oral examination), and from the atheromatous plaques (APs). We investigated 
the general and oral conditions from each patient and performed next-generation sequencing (NGS) analysis for all bacterial 
samples. There were no significant differences between both groups concerning general conditions. However, the microbiome 
patterns of the gingival pocket showed differences depending on the absence or presence of periodontitis, while those of 
the tongue surface were relatively similar. The microbiome pattern of the atheromatous plaques was entirely different from 
that on the tongue surface and gingival pocket, and oral bacteria were seldom detected. However, the microbiome pattern 
in atheromatous plaques was different in the presence or absence of periodontitis. These results suggested that oral bacteria 
did not affect the formation of atheromatous plaques directly.
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Abbreviations
NGS  Next-generation sequencing
LDL  Low-density lipoprotein
Pg  Porphyromonas gingivalis
Aa  Aggregatibacter actinomycetemcomitans
Co  Capnocytophaga ochracea
rRNA  Ribosomal RNA
PPD  Pocket probing depth
BOP  Rate of bleeding on probing
PCA  Principal component analysis
Introduction
Periodontitis is a predominant oral infectious disease in 
which an excessive immune response directed at the micro-
biome on the tooth surface destroys the periodontal tissue, 
forming periodontal pockets. The microbiome in these pock-
ets includes pathogenic anaerobic bacteria that can form bio-
films, which are inherently more resistant to antibacterial 
compounds and host immune components [1]. The mature 
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biofilm causes further periodontitis progression because of 
the prolonged inflammation associated with the protracted 
immune response. Therefore, periodontitis has two main 
features: it is an infectious disease caused by microbiome 
imbalance and a chronic inflammatory disease caused by a 
dysregulated immune response.
These two characteristics of periodontitis are shared by 
various systematic diseases, including diabetes, arterio-
sclerosis, cardiovascular diseases such as stroke and infec-
tive endocarditis, brain diseases, cancer, and non-alcoholic 
steatohepatitis, and also these features increase the risks 
of preterm birth and low birth weight [2–9]. Arterioscle-
rosis includes atherosclerosis, in which an atherosclerotic 
plaque is formed on the blood vessel walls [10]. Briefly, 
the mechanism of plaque formation involves an endothelial 
dysfunction with various causes, such as hypertension, dia-
betes, obesity, and high cholesterol levels. All feature the 
accumulation of low-density lipoprotein (LDL) cholesterol 
between the intimal and medial endothelial surfaces. Mac-
rophages in atherosclerotic lesions actively participate in 
lipoprotein ingestion and accumulation giving rise to foam 
cells filled with lipid droplets, and thus, the accumulation 
of those foam cells contributes to lipid storage and the con-
sequent atherosclerotic plaque growth [11]. An association 
between atherosclerosis and periodontitis has been sug-
gested in some epidemiology reports. Moreover, bacterial 
investigations aimed at detecting periodontal bacteria in 
the atherosclerotic plaque have been conducted [12–14]. 
Although observational data support an association between 
periodontitis and atherosclerotic vascular disease, the data 
do not yet justify a causative relationship [15]. Multiple 
common factors that include diabetes, high blood pressure, 
dyslipidemia, and smoking habits affect the disease progres-
sion. However, there are little data concerning the direct 
involvement of periodontal bacteria in the development of 
atherosclerotic vascular disease [16, 17].
Porphyromonas gingivalis (Pg) is the most promi-
nent pathogen in periodontal disease. Many studied have 
addressed the association between Pg and atherosclerotic 
vascular disease in clinical and animal models. Some clini-
cal analyses sought to detect the DNA of Pg in atheroscle-
rotic plaques [18–21]. Zaremba et al. reported that Pg was 
detected in atherosclerotic plaque of 10 individuals out of 
20 by DNA hybridization method [22]. Szulc et al. reported 
that Pg was detected in only 3 samples from patients with 
coronary artery disease (9.4%), whereas DNA of Pg was 
detected in 15 atheromatous plaques from patients scheduled 
for carotid endarterectomy (48.4%) [23]. Sliva Filho et al. 
reported that there was a significant difference in microbial 
diversity between subgingival biofilm and atheroma plaques; 
however, 17 identical phylotypes include Pg were found in 
both samples [24]. We also reported a significant correla-
tion between plasma IgG titer levels against Pg with LDL 
cholesterol levels, both of which are high in patients with 
severe periodontitis [25]. Furthermore, in a mice model, an 
association between periodontitis and atherosclerotic vascu-
lar disease was demonstrated using Pg [26]. Ford et al. [27] 
also reported that intraperitoneal immunizations with Pg 
enhance the levels of serum antibodies to Pg and atheroscle-
rosis. Hypercholesterolemia and subsequent arteriosclerosis 
occur in apolipoprotein E knock-out mice  (ApoE−/−), which 
have been used to investigate the association between peri-
odontitis and atherosclerosis. Lalla et al. [2] reported that 
oral infection with Pg accelerates the early atherosclerosis 
in  ApoE−/− mice. Maekawa et al. [28] reported that chronic 
oral infection with Pg accelerates atheroma formation in 
 ApoEshl mice. However, the authors did not detect Pg DNA 
(16S-ribosomal RNA) by PCR in the aortic valve. Therefore, 
how Pg induce atheroma formation is still unknown.
Microbiome analysis has typically involved bacterial cul-
ture [29]. However, recent comprehensive bacterial analysis 
using the gene for 16S-ribosomal RNA (rRNA) has been 
successful in detecting bacteria that are difficult to culti-
vate [30]. NGS has become a popular means of examining a 
large number and volume of samples [31]. In this study, the 
association between periodontitis and atherosclerosis in the 
context of the microbiome in the oral cavity and atheroscle-
rotic plaque was investigated by NGS.
Materials and methods
Ethics statement
This study was approved by the ethics committee of Okay-
ama University Graduate School of Medicine, Dentistry, and 
Pharmaceutical Sciences and Okayama University Hospital 
(Authorization Number: 1603–059) and Brain Attack Center 
Ota Memorial Hospital (Authorization Number: 121). All 
enrolled patients provided written informed consent for the 
use of their resected tissue and oral samples.
Participants
The study focused on 12 patients who visited Brain Attack 
Center Ota Memorial Hospital between April 2016 and 
March 2018, and who were diagnosed with internal carotid 
artery stenosis. The patients were ≥ 40 years of age, under-
went carotid endarterectomy, had more than ten teeth, and 
consented to participate.
Samples
We harvested atheromatous plaques from the carotid artery 
walls extracted during carotid endarterectomy. Bacteria 
in the gingival pocket were collected using absorbent 
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paper points (United Dental Manufactures Inc., Johnson 
City, TN, USA). Three paper points were inserted into 
patients’ gingival pockets and were harvested after 1 min. 
We chose the deepest pocket using the six-point exami-
nation. Each item was put them into an Eppendorf tube 
containing PBS. Later, bacteria from the tongue surface 
were collected using forensic swabs (Sarstedt AG & Co. 
Nümbrecht, Germany) by wiping the dorsum portion of 
each tongue several times. Each swab was placed in a tube 
and immediately stored at − 80 °C until DNA purification. 
Blood samples were collected from each patient and serum 
was prepared as previously described [32].
Oral examination
Periodontal examinations were performed to evaluate the 
average pocket probing depth (PPD) and rate of bleed-
ing on probing (BOP) for each tooth of each patient. The 
patients were then divided into three groups according to 
the latest classification system for periodontal diseases and 
conditions [33]. In particular, we defined four patients into 
a control group (H1–H4, they belong to the classification 
as clinical gingival health on an intact periodontium and 
clinical gingival health on a reduction periodontium/sta-
ble periodontitis patient), four patients into a mild peri-
odontitis group (they belong to the classification as peri-
odontitis/stage II: moderate periodontitis; excluded from 
further analysis), and four severe periodontitis (P1–P4, 
they belong to the classification as periodontitis/stage III: 
severe periodontitis with potential for additional teeth 
loss).
DNA purification
APs were extensively minced using a scalpel and sus-
pended in phosphate-buffered saline (PBS). The collected 
material from paper points and swabs were resuspended 
using PBS. One milliliter of each resuspended bacterial 
sample was transferred to 2 ml Lysing Matrix B tubes (MP 
Biomedicals, Santa Ana, CA, USA) containing 0.1 mm 
silica beads and 500 μl ATL buffer (Qiagen, Hilden, Ger-
many). The contents of each tube were homogenized using 
FastPrep 24 (MP Biomedicals, Santa Ana, CA, USA) for 
45 s at 6.5 m/s. Bacterial DNA was extracted using the 
QIAamp DNA Microbiome Kit (Qiagen, Hilden, German) 
according to the manufacturer’s instructions. The quality 
and quantity of the DNA were verified using the NanoDrop 
2000 spectrophotometer (Thermo Fisher Scientific, Wilm-
ington, DE, USA) and the PicoGreen dsDNA assay kit 
(Life Technologies, Grand Island, NY, USA).
Library preparation, sequencing, and analysis 
of 16S rRNA
The V3 and V4 regions of the 16S rRNA were amplified 
using the forward primer 5′-TCG TCG GCA GCG TCA GAT 
GTG TAT AAG AGA CAG CCT ACGGGNGGC WGC AG, and 
the reverse primer 5′-GTC TCG TGG GCT CGG AGA TGT 
GTA TAA GAG ACA GGA CTACHVGGG TAT CTA ATC C. 
(The most recent analysis of the variable portions V1–V3 
should be preferred; however, we had used V3 and V4 at the 
time this study was performed.) Thermal cycling conditions 
were 98 °C for 3 min; 25 cycles of 98 °C for 30 s, 55 °C for 
30 s, and 72 °C for 30 s; and a final extension at 72 °C for 
5 min. After PCR clean-up step using AMpure XP Beads 
(Beckman Coulter, Inc., Brea, CA, USA), a second PCR was 
performed to add sequencing adapters and dual-index bar-
codes to the amplicon target to distinguish amplicons from 
each sample using the same reaction conditions with only 
eight cycles instead. After the PCR clean-up step, the qual-
ity and quantity of the amplicon were verified using KAPA 
library quantification kit (KAPA Biosystems Inc., Wilming-
ton, MA, USA). Aliquots (5 μL) of the diluted amplicon 
from each library were combined to form pooling librar-
ies. Six pM of pooling libraries with PhiX was sequenced 
using the  MiSeq® system (Illumina Inc., San Diego, CA, 
USA). The obtained sequence was analyzed using the CLC 
Microbial Genomics Module of the CLC Genomics Work-
bench (CLC bio, Aarhus, Denmark). Briefly, we extracted 
5911 bacteria having sequences that passed both those being 
retained and operational taxonomic units (OTUs) selected 
based on a 97% similarity with a minimum of ten reads 
representing each OTU [34]. Principal component analy-
sis (PCA) and clustering analysis were performed using R 
statistical software [35]. We also performed co-occurrence 
analysis for the 13 highly detected operational taxonomic 
units from control and periodontitis samples using the Quan-
titative Insights Into Microbial Ecology approach (QUIIME 
1) [36] (we want to clarify that at the time, we did the analy-
sis of this study; QUIIME 1 was valid. Currently—from Jan-
uary 1st 2018—QUIIME 1 has been replaced by QUIIME2).
Plasma IgG antibody titer test against periodontal 
bacteria
Plasma IgG antibody titer test against periodontal bacte-
ria was determined as described previously [23, 32, 37, 
38]. Bacterial antigens used were sonicated preparations 
of Aggregatibacter actinomycetemcomitans (Aa) Y4, Aa 
ATC29523, Aa SUNY67, Eichenerra corrodens (Ec) 
FDC1073, Fusobacterium nucleatum (Fn) ATCC25586, 
Prevotella intermedia (Pi) ATCC25611, Prevotella nigre-
scens (Pn) ATCC33563, Capnocytophaga ochracea (Co) 
S3, Porphyromonas gingivalis (Pg) FDC381, Pg SU63, 
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Treponema denticola (Td) ATCC35405, and Tannerella for-
sythia (Tf)ATCC43037. The sera from five healthy partici-
pants without periodontitis (24–29 years of age) were pooled 
and used to calibrate the analyses. Standard titration curves 
were prepared using serial dilutions of this pooled control 
serum. The absorbance of each sample after reaction was 
defined as an ELISA unit (EU), with 100 EUs corresponding 
to a 1: 3200 dilution of the calibrator sample [32]. According 
to the formula for clinical use, the mean ± 2 standard devia-
tions of the controls, based on the reported dataset of IgG 
titers to individual pathogens among five healthy individu-
als, was defined as the standard value of 1.
Statistical analysis
The statistical analysis was performed using the Mann–Whit-
ney U Test. A P value of 0.05 was considered significant and 
was determined using SPSS Ver. 23 (SPSS Inc., Chicago, 
IL, USA) for all the experimental results.
Results
General conditions of the patients were evaluated based 
on age, disease history, body mass index, blood pressure, 
C-reactive protein, cholesterol, and HbA1c (Table 1). There 
were no significant differences between both groups in terms 
of age, sex, other disease such as diabetes, and markers of 
inflammation and cholesterol. We evaluated the periodontal 
condition for each patient group from oral examination and 
plasma IgG antibody titer test (Table 2). Serum IgG antibody 
titer was significantly higher in those with periodontitis that 
in control group for Aggregatibacter actinomycetemcomitans 
(Aa) Y4, Aa ATCC29523, Aa SUNY67, Capnocytophaga 
ochracea (Co) S3, and Pg FDC381.
The microbiome pattern of tongue surface was relatively 
similar between control samples and periodontitis samples 
(Fig. 1a). Among them, the ratio of Filifactor was signifi-
cantly higher in periodontitis patients than in the respective 
controls (Fig. 1b).
The microbiome pattern of gingival pockets was nota-
bly different between the control and periodontitis samples 
(Fig. 2a). The ratio of Rothia and Neisseria was lower in 
periodontitis than in control samples. Conversely, the ratios 
of Fusobacterium and Filifactor were higher in periodontitis 
than in control samples (Fig. 2a, b). The ratio of Desulfob-
ulbus was significantly higher in periodontitis samples than 
in controls (Fig. 2b).
The majority of the bacteria found in the APs microbi-
ome belonged to the soil bacterial families Burkholderi-
ales, Bacillale, and Rhizobiales. Their ratios were similar 
between periodontitis and control patients (Fig. 3). The ratio 
of Sphingomonadales was higher in periodontitis samples 
than in control samples.
Three gingival pocket bacteria from periodontitis (P2, P3, 
P4; red) and one control sample (H4; blue) were positioned 
in the center right side of the PCA graph (separated by a 
red solid circle), three gingival pocket bacteria from con-
trol samples (H1, H2, H3), and one gingival bacteria from 
periodontitis (P4) were located into the center of the plot 
(separated by a blue solid circle), respectively (Fig. 4). The 
two circular locations were sufficiently separated. Tongue 
surface bacteria from periodontitis samples were located in 
the center left side of the panel (P1, P2, P3, P4) (separated 
by a red dotted circle). This position was slightly toward 
to the right side than that of the control samples (H1, H2, 
H3, H4) (separated by a blue dotted circle). These two cir-
cular locations were comparatively closer. The bacteria in 
atheromatous plaques were located towards the lower mid-
dle region of the plot (separated by a green solid circle), 
and control and periodontitis atheroma samples could not 
be clearly distinguished between them. The atheromatous 
plaques bacteria were located far away from the oral samples 
(tongue surface and gingival pockets).
Similar to the PCA results, bacteria from oral samples 
(tongue surface and gingival pocket) and atheromatous 
plaques were completely different (Fig. 5). However, 75% 
Table 1  Characteristics of study participants
Characteristic Control (n = 4) Periodontitis (n = 4) p
Man, no. (%) 4 (100) 4 (100)
Age, years 74.8 ± 4.3 75.0 ± 3.2 0.884
Current smoker, no. 
(%)
0 1 (25)
Known diabetes, no. 
(%)
2 (50) 2 (50)
Known hypertension, 
no. (%)
2 (50) 2 (50)




Body-mass index 25.7 ± 3.2 25.4 ± 1.7 0.885
Blood pressure, mmHg
 Systolic 128.5 ± 24.2 134.5 ± 16.3 0.772
 Diastolic 69.3 ± 22.3 72.5 ± 14.2 0.663
CRP, mg/dL 0.32 ± 0.32 0.16 ± 0.17 0.386
Leukocyte count, × 104/
μL
6535 ± 754 6293 ± 983 0.564
Cholesterol, mg/dL 163.3 ± 31.7 187 ± 40.3 0.309
 High-density lipo-
protein
31.7 ± 5.1 42.1 ± 2.9 0.248
 Low-density lipopro-
tein
79.8 ± 8.7 118.5 ± 33.9 0.248
Triglycerides, mg/dL 234 ± 224.4 164.5 ± 107.3 0.773
HbA1c (NGSP), % 6.1 ± 0.6 6.8 ± 0.9 0.248
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of atheromatous plaques bacteria from periodontitis were 
located at the lower part in the cluster and 75% of atheroma-
tous plaques bacteria from controls were located at the upper 
part of the periodontitis samples.
We evaluated the correlation of the microbiome in ather-
omatous plaques between the control group and periodontitis 
group. In both groups, the major bacteria of the network 
were Agrobacterium, Delftia, and Rhizobium. However, the 
network around Cutibacterium was different between control 
and periodontitis samples (Fig. 6).
Discussion
In this research, we performed a pilot study regarding a 
comprehensive microbiome analysis of the internal carotid 
artery stenosis in patients affected with and without peri-
odontitis. We harvested bacteria samples from the tongue 
surface, gingival pockets, and atheromatous plaques from 
each patient and performed NGS analysis. The microbiome 
in the oral cavity was higher for the periodontal bacterial 
pathogens Fusobacterium and Filifactor in the periodontitis 
group compared to the control group. In particular, the ratio 
of Filifactor on the tongue surface was significantly higher 
in the periodontitis group in comparison to the control 
group. Conversely, the ratio of Rothia and Neisseria in gin-
gival pockets, which are constituents of the normal bacterial 
flora in a healthy oral cavity, was lower in the periodontitis 
group than in the control group [39, 40]. Thus, remarkably, 
the ratio of normal bacteria in gingival pockets and on the 
tongue surface decreased, while the ratio of pathogenic bac-
teria increased.
As pathogenic factors for periodontitis, Red complex spe-
cies (Pg, T. denticola, and T. forsythia) have been the focus 
of functional investigations [41]. Although there is no doubt 
regarding their relationship to periodontitis development, the 
microbiome does not contain just the pathogenic bacteria, 
but includes a mixture of various and diverse species of bac-
teria, to comprise the total population ultimately affecting 
the development of this disease [42]. It has been suggested 
that 17 novel bacteria including Filifactor alosis probably 
induce periodontitis, even though these bacteria were not 
previously thought to be periodontitis-specific pathogenic 
bacteria [43].
The normal bacterial flora in the oral cavity, which was 
previously disregarded as insignificant, is actually very cru-
cial for periodontitis development or progression. In general, 
pathogenic bacteria, such as Pg, configure the microbiome 
with the normal bacteria flora [44]. If the balance of path-
ogenic and normal bacteria in the microbiome is lost for 
some reason, the microbiome increases its pathogenicity and 
induces the disease. Therefore, a comprehensive microbiome 
analysis is necessary to investigate normal as well as patho-
genic bacteria composition.
To investigate the possibility that periodontal bacteria 
might contribute to atheromatous plaques formation directly 
on the vascular wall by hematogenous spread, NGS analysis 
was done using the atheromatous plaque samples. Previous 
reports established that Pg induces the expression of vascu-
lar cell adhesion molecule 1 from vascular endothelial cells, 
Table 2  Periodontal disease 
infection of study participants
Variable Controls (n = 4) Patients (n = 4) p
Total no. of teeth 24.8 ± 2.2 19.8 ± 7.4 0.561
Periodontal pocket depth
 1–3 mm, (%) 97.9 ± 1.8 71.4 ± 4.5 0.021
 4–6 mm, (%) 2.0 ± 1.8 27.2 ± 4.3 0.021
 Over 7 mm, (%) 0.2 ± 0.3 2.9 ± 2.1 0.026
Sites with gingival bleeding (%) 7.8 ± 8.1 24.0 ± 12.8 0.081
Serume IgG antibody titer test against periodontal bacteria
 A. actinomycetemcomitans Y4 − 0.06 ± 0.49 1.85 ± 1.33 0.021
 A. actinomycetemcomitans ATCC29523 0.02 ± 0.38 1.96 ± 0.83 0.021
 A. actinomycetemcomitans SUNY67 0.04 ± 0.71 2.35 ± 1.21 0.021
 C. ochracea S3 − 2.70 ± 2.53 1.94 ± 3.08 0.043
 E. corrodens FDC1073 − 0.43 ± 0.91 0.43 ± 1.68 0.564
 F. nucleatum ATCC25586 − 0.11 ± 1.52 2.42 ± 3.82 0.248
 P. nigrescens ATCC33563 − 0.95 ± 1.44 − 0.63 ± 0.63 0.248
 P. intermedia ATCC25611 − 0.22 ± 0.98 0.50 ± 1.37 0.773
 P. gingivalis FDC381 − 0.98 ± 0.31 1.83 ± 1.63 0.021
 P. gingivalis SU63 − 0.70 ± 0.46 2.58 ± 4.25 0.083
 T. denticola ATCC35405 − 0.03 ± 2.14 0.37 ± 1.94 0.564
 T. forsythia ATCC43037 − 0.90 ± 0.25 −0.41 ± 0.80 0.248
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and promotes thrombus formation by macrophage invasion 
into blood vessels, resulting in platelet aggregation [45, 46]. 
Another report demonstrated that Pg infection accelerates 
the progression of atherosclerosis in a heterozygous apolipo-
protein E-deficient murine model [26]. In the present study, 
oral bacteria were barely detectable in atheromatous plaques, 
regardless of the presence or absence of periodontitis. The 
patterns of the microbiome in atheromatous plaques were 
entirely different on the tongue surface and in gingival pock-
ets. A prior study reported the detection of some oral bacte-
ria in the atheromatous plaques [47]. However, other authors 
reported that Pg infection in an animal model induced ath-
eromatous plaque formation, although this bacterium was 
actually not detected in the atheromatous plaques [48]. Our 
Fig. 1  Characterization of 
microbiome on the tongue 
surface. The average ratio of the 
bacteria on the tongue surface 
from control and periodontitis 
patient samples is presented. a 
Bacterial genera are indicated. b 
Thirteen bacterial species were 
highly detected by NGS analy-




data enables us to conclude that it is unlikely that the oral 
bacteria spread hematogenously and directly induce the for-
mation of atheromatous plaque on the aortic wall.
The co-occurrence analysis of the microbiome in ath-
eromatous plaques revealed that the most significant bac-
teria were Agrobacterium, Delftia, and Rhizobium, which 
constituted the network in both groups. Although these 
are soil bacteria, they were also previously detected in 
atheromatous plaques [32]. Another significant bacte-
rium, Cutibacterium, configured the network in the con-
trol group. The relationship with Cutibacterium was dif-
ferent among the control and periodontitis groups. This 
bacterium is categorized as a normal bacterium present 
on the skin and in the gut, although it was also detected in 
Fig. 2  Characterization of 
microbiome in gingival pockets. 
The average ratios of the 
bacteria in gingival pockets 
from control and periodontitis 
samples are shown. a Bacterial 
genera are indicated. b Thirteen 
bacteria that were highly 
detected from the NGS analysis. 




atheromatous plaques [49]. Cutibacterium reportedly can 
cause sarcoidosis, sepsis, and infective endocarditis, and 
it was also found that heat-killed Cutibacterium render 
mice very susceptible to lipopolysaccharide (LPS) toxicity. 
Cutibacterium also promotes the production of cytokines, 
such as interleukin-12, interferon-gamma, and Toll-like 
receptor 4 [50]. Presently, it is conceivable that LPS pro-
duced by periodontal bacteria activated Cutibacterium 
in the blood vessels, which then form the atheromatous 
plaques. In this scenario, the difference of the network 
in atheromatous plaques between the control and peri-
odontitis samples might be caused by LPS that is spread 
hematogenously, as well as by the chronic inflammatory 
effect. Recently, it was reported that the production of 
trimethylamine-N-oxide, which promotes atherosclerosis, 
depends upon the metabolism of the intestinal microbiome 
[51]. Some previous studies and the present data indicate 
that the loss of microbiome balance in the human body 
affects the development of atherosclerosis. Periodontitis 
has a great effect on the microbiome configuration in the 
oral cavity and promotes the formation of various meta-
bolic products. The metabolic products of microbiome 
or the host inflammatory response might indirectly influ-
ence the composition of atheromatous plaques. However, 
this detailed mechanism of atherosclerosis development 
remains largely unknown. In a further study, we intend 
to investigate the relationship between periodontitis and 
atherosclerosis. We also wish to point out the limitations 
of this study related to the software analysis. These analy-
sis methods are progressing every day. For example, the 
current segmentation systems have a good behavior in the 
identification of the genus, although a moderate behavior 
in the identification of the species was almost null in the 
strain recognition.
Fig. 3  Characterization of microbiome in atheromatous plaques. 
The average ratio of the bacteria in gingival pocket from our patients 
(control and periodontitis samples) is depicted and the order of the 
bacteria is shown. Thirteen bacteria were highly expressed from the 
NGS analysis
Fig. 4  Comparison of PCA results between control and periodontitis 
samples. The PCA results from each sample are identified tagged as 
follows: tongue surface: open square; gingival pocket: open circle; 
atheromatous plaques: open triangle; controls: blue color; periodon-
titis: red color. Blue solid circle: three gingival pocket bacteria from 
control samples and one gingival pocket from periodontitis. Red solid 
circle: three periodontitis gingival bacteria pocket and one healthy 
gingival pocket sample. Red dotted circle: four tongue surface from 
periodontitis samples. Blue dotted circle: four tongue surface from 
control samples. Green solid circle: four atheroma plaque samples 
from controls and four atheroma samples from periodontitis
Fig. 5  Comparison of clustering analysis results between control and 
periodontitis samples. The clustering analysis results from each sam-
ple were tagged as follows: T: tongue surface; P: gingival pocket; A: 
atheromatous plaques. Blue text represents control samples and red 




The ratio of oral bacteria in atheromatous plaques was 
remarkably low, and the microbiome pattern in the ath-
eromatous plaques was entirely different from that found 
in the oral microbiome. There is a possibility that oral 
bacteria do not directly induce the atheromatous plaque 
configuration, but this fact was not proved from this study. 
The microbiome pattern and the correlation of the micro-
biome in atheromatous plaques were different between 
the controls and periodontitis samples. Thus, metabolic 
products of the microbiome, or the host’s inflammatory 
response, might indirectly affect the atheromatous plaque 
configuration. To confirm this hypothesis, further studies 
of both epidemiology and animal studies are needed.
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